Cargando…
Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and Migration
Microparticle and nanoparticle formulations are widely used to improve the bioavailability of low-solubility drugs and as vehicles for organ- and tissue-specific targeted drug delivery. We investigated the effect of a novel, controlled-release form of a bioactive lipid, cyclic phosphatidic acid (cPA...
Autores principales: | Tsukahara, Tamotsu, Murakami-Murofushi, Kimiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449289/ https://www.ncbi.nlm.nih.gov/pubmed/23008752 http://dx.doi.org/10.1038/srep00687 |
Ejemplares similares
-
Cyclic phosphatidic acid relieves osteoarthritis symptoms
por: Gotoh, Mari, et al.
Publicado: (2014) -
Cyclic Phosphatidic Acid Stimulates cAMP Production and Inhibits Growth in Human Colon Cancer Cells
por: Tsukahara, Tamotsu, et al.
Publicado: (2013) -
Protection of Neuroblastoma Neuro2A Cells from Hypoxia-Induced Apoptosis by Cyclic Phosphatidic Acid (cPA)
por: Gotoh, Mari, et al.
Publicado: (2012) -
Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain
por: Kakiuchi, Yasutaka, et al.
Publicado: (2011) -
PPARγ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid
por: Tsukahara, Tamotsu
Publicado: (2013)